Intranasal SB-705498 in Allergic Rhinitis (AR) Patients

Status:
Completed

Trial end date:
2011-07-07

Target enrollment:

Participant gender:

This study is designed to look at the affect of SB-705498 on allergic rhinitis symptoms induced by an allergen chamber challenge.

Phase 2

GlaxoSmithKline